A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3

Experimental Hematology

Volumn 26, Issue 3, 1998, Pages 198-206

  Kanatani, Y ^a   Makishima, M ^a   Ishikawa, I ^a   Ogasawara, Y ^a   Kawahara, N ^a   Motoyoshi, K ^a   Nagata, N ^a   Honma, Y ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

1 ,25 dihydroxyvitamin D3; Differentiation; Novel uracil analog

Indexed keywords

6 CHLORO 5 (2 PROPENYL)URACIL; CALCITRIOL; CALCITRIOL RECEPTOR; RETINOID X RECEPTOR; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; CALCITRIOL; CELL DIFFERENTIATION; CELL NUCLEUS; DNA-BINDING PROTEINS; GROWTH INHIBITORS; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; NITROBLUE TETRAZOLIUM; OXIDOREDUCTASES; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR CELLS, CULTURED; URACIL;

ATRA;

EID: 0031906518     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)